首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Hexadecylphosphocholine: Skin Treatment of Cutaneous leishmania
【24h】

Hexadecylphosphocholine: Skin Treatment of Cutaneous leishmania

机译:十六烷基磷酸胆碱:皮肤利什曼病的皮肤治疗

获取原文
获取原文并翻译 | 示例
       

摘要

Human leishmaniasis is a parasitic disease caused by trypnosomatid of the genus leishmania,transmitted by the bite of a sand fly of genus phlebotomus,a characteristic of all leishmanial infections in the intracellular parasitism of macrophages. Various species of leishmania have been identified causing the disease ranging from simple cutaneous to Visceral leishmaniasis. Hexadecylphosphocholine (HePC),a novel phospholipids derivative,was tested against leishmania major and leishmania tropica,the causative agent of Cutaneous leishmaniasis. Human volunteer were cured completely,when treated topically with an ointment comprising 15 % HePC and 12 % methyl benzethonium chloride in simple ointment base twice daily for 10 d. No parasites were detected in tissue smears or in culture from treated cutaneous lesions.
机译:人类利什曼病是一种由利什曼原虫的胰疟原虫引起的寄生虫病,是由细支气管gen沙蝇的叮咬传播的,这是巨噬细胞胞内寄生虫的所有利什曼原虫感染的特征。已经鉴定出多种利什曼原虫引起该疾病,其范围从简单的皮肤病到内脏利什曼病。测试了一种新型的磷脂衍生物十六烷基磷酸胆碱(HePC)对抗皮肤利什曼病的病原体大利什曼原虫和热带利什曼原虫。用含15%HePC和12%甲基苄索氯铵的软膏在简单的软膏基质中局部治疗,每天两次,将志愿者完全治愈。在组织涂片或经治疗的皮肤病灶的培养物中未检测到寄生虫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号